Able Sciences

Princeton, United States · Founded 2023 · $7.5M raised

Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$7.5M
Last Round
$7.5M SeedJan 2026
Rounds
1

About

Able Sciences is a biotechnology company developing off-the-shelf, allogeneic cell therapies built on an RNA-based cell-engineering platform. Its lead programs use natural killer (NK) cells engineered to express multiple kill signals in a single step, creating a multivalent, combination-style approach aimed at solid tumors and autoimmune disorders. Backed by SOSV's IndieBio accelerator, the seed-stage company was co-founded in 2023 by CEO Jolly Mazumdar and CSO Thimmaiah Chendrimada.

Summary

Able Sciences is a Biotech company based in Princeton, United States, founded in 2023. It has raised $7.5M in total across 1 round, most recently a $7.5M Seed round in Jan 2026. Investors include SOSV and IndieBio.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJan 2026
$7.5M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Able Sciences on Indexed.vc
<a href="https://indexed.vc/companies/able-sciences"><img src="https://indexed.vc/api/badge/company/able-sciences" alt="Able Sciences on Indexed.vc" width="260" height="76" /></a>